These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9532343)
1. A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Tyrrell J; Cosgrave M; Hawi Z; McPherson J; O'Brien C; McCalvert J; McLaughlin M; Lawlor B; Gill M Biol Psychiatry; 1998 Mar; 43(6):397-400. PubMed ID: 9532343 [TBL] [Abstract][Full Text] [Related]
2. ApoE2 allele, Down's syndrome, and dementia. Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Ragbavan R; Khin-Nu C; Tyner S; Day K; Crook R; Hardy J; Roberts GW Ann N Y Acad Sci; 1996 Jan; 777():255-9. PubMed ID: 8624094 [TBL] [Abstract][Full Text] [Related]
3. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome. Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023 [TBL] [Abstract][Full Text] [Related]
4. The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. Del Bo R; Comi GP; Bresolin N; Castelli E; Conti E; Degiuli A; Ausenda CD; Scarlato G J Neurol Sci; 1997 Jan; 145(1):87-91. PubMed ID: 9073034 [TBL] [Abstract][Full Text] [Related]
5. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. van Gool WA; Evenhuis HM; van Duijn CM Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609 [TBL] [Abstract][Full Text] [Related]
7. The role of -850 tumor necrosis factor-alpha and apolipoprotein E genetic polymorphism in patients with Down's syndrome-related dementia. Lucarelli P; Piciullo A; Verdecchia M; Palmarino M; Arpino C; Curatolo P Neurosci Lett; 2003 Nov; 352(1):29-32. PubMed ID: 14615042 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the APOE alleles impact in Down's syndrome. Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E allele distribution in parents of Down's syndrome children. Avramopoulos D; Mikkelsen M; Vassilopoulos D; Grigoriadou M; Petersen MB Lancet; 1996 Mar; 347(9005):862-5. PubMed ID: 8622392 [TBL] [Abstract][Full Text] [Related]
10. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224 [TBL] [Abstract][Full Text] [Related]
11. [Apolipoprotein E genotypes in patients investigated for dementia]. Johannsen P; Jakobsen JK; Jørgensen AL Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872 [TBL] [Abstract][Full Text] [Related]
12. Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: no effect on the presence of dementia. Tyrrell J; Cosgrave M; McPherson J; Hawi Z; Trulock V; Calvert J; Lawlor B; Gill M Am J Med Genet; 1999 Dec; 88(6):616-20. PubMed ID: 10581479 [TBL] [Abstract][Full Text] [Related]
13. The impact of apolipoprotein E on dementia in persons with Down's syndrome. Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Arias-Vasquez A; Sayed-Tabatabaei FA; Vergeer-Drop J; Eikelenboom P; van Gool WA; van Duijn CM Neurobiol Aging; 2008 Jun; 29(6):828-35. PubMed ID: 17250929 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475 [TBL] [Abstract][Full Text] [Related]
15. Little evidence of reduced survival to adulthood of apoE epsilon4 homozygotes in Down's syndrome. Edland SD; Wijsman EM; Schoder-Ehri GL; Leverenz JB Neuroreport; 1997 Nov; 8(16):3463-5. PubMed ID: 9427308 [TBL] [Abstract][Full Text] [Related]
16. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE Neuroreport; 1995 Jul; 6(11):1513-6. PubMed ID: 7579137 [TBL] [Abstract][Full Text] [Related]
17. [APOE gene polymorphisms associated with Down syndrome in Colombian populations]. Rengifo L; Gaviria D; Serrano H Biomedica; 2012 Jun; 32(2):224-32. PubMed ID: 23242296 [TBL] [Abstract][Full Text] [Related]
18. Relation between apolipoprotein E genotype, hepatitis B virus status, and thyroid status in a sample of older persons with Down syndrome. Percy ME; Potyomkina Z; Dalton AJ; Fedor B; Mehta P; Andrews DF; Mazzulli T; Murk L; Warren AC; Wallace RA; Chau H; Jeng W; Moalem S; O'Brien L; Schellenberger S; Tran H; Wu L Am J Med Genet A; 2003 Jul; 120A(2):191-8. PubMed ID: 12833399 [TBL] [Abstract][Full Text] [Related]
19. Onset of dementia is associated with age at menopause in women with Down's syndrome. Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653 [TBL] [Abstract][Full Text] [Related]
20. Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome. Schupf N; Patel B; Silverman W; Zigman WB; Zhong N; Tycko B; Mehta PD; Mayeux R Neurosci Lett; 2001 Apr; 301(3):199-203. PubMed ID: 11257432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]